Toru Hifumi

InstitutionKagawa University Hospital
AddressKagawa
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 3 publications in Spetember 2020
    All Publications
    Bar chart showing 95 publications over 12 distinct years, with a maximum of 14 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Banno A, Hifumi T, Okamoto H, Masaki M, Seki K, Isokawa S, Otani N, Hayashi K, Ishimatsu S. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave. BMC Infect Dis. 2021 Feb 09; 21(1):163. PMID: 33563218.
      Citations: 3     Fields:    Translation:Humans
    2. Fujimaru T, Shimada K, Hamada T, Watanabe K, Ito Y, Nagahama M, Taki F, Isokawa S, Hifumi T, Otani N, Nakayama M. Development of acute kidney injury with massive granular casts and microscopic hematuria in patients with COVID-19: two case presentations with literature review. Ren Replace Ther. 2020; 6(1):59. PMID: 33510902.
      Citations: 1     
    3. Ishikawa Y, Hifumi T, Otani N, Miyamichi R, Urashima M, Takeda S, Ishimatsu S. Relationship Between the Number of Patients Visiting Emergency Department and Tokyo Health System's Capacity During Early Stages of the First Wave of COVID-19. SN Compr Clin Med. 2020; 2(11):2158-2160. PMID: 33073172.
      Citations: 1     
    4. Ishikawa Y, Hifumi T, Urashima M. Critical Care Medical Centers May Play an Important Role in Reducing the Risk of COVID-19 Death in Japan. SN Compr Clin Med. 2020 Sep 29; 1-4. PMID: 33015554.
      Citations:    
    5. Hifumi T, Ishikawa Y, Otani N, Ishimatsu S, Urashima M. Tokyo and New York: A Study in the Contrasting Effects of Socioeconomic Status on Coronavirus Disease 2019 Outcomes. Crit Care Explor. 2020 Sep; 2(9):e0221. PMID: 32984839.
      Citations:    
    6. Soh M, Hifumi T, Isokawa S, Otani N, Ishimatsu S. The application of 6S in the care of COVID-19 patients: a Japanese perspective. Crit Care. 2020 09 01; 24(1):542. PMID: 32873318.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    7. Hifumi T, Isokawa S, Otani N, Ishimatsu S. Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients. Crit Care. 2020 08 12; 24(1):497. PMID: 32787901.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    8. Soh M, Hifumi T, Iwasaki T, Miura Y, Otani N, Ishimatsu S. Impaired mental health status following ICU care in a patient with COVID-19. Acute Med Surg. 2020 Aug 11. PMID: 32837734.
      Citations: 2     
    9. Soh M, Hifumi T, Isokawa S, Shimizu M, Otani N, Ishimatsu S. The authors' response: Propofol in COVID 19: From basic science to clinical impact. Am J Emerg Med. 2021 07; 45:528. PMID: 32690223.
      Citations:    Fields:    Translation:Humans
    10. Soh M, Hifumi T, Isokawa S, Shimizu M, Otani N, Ishimatsu S. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Am J Emerg Med. 2021 05; 43:274. PMID: 32622686.
      Citations:    Fields:    Translation:Humans
    11. Soh M, Hifumi T, Isokawa S, Shimizu M, Otani N, Ishimatsu S. The authors' response: Propofol and sedation in patients with coronavirus disease 2019. Am J Emerg Med. 2021 Apr; 42:251. PMID: 32611498.
      Citations: 1     Fields:    Translation:HumansCells
    12. Soh M, Hifumi T, Isokawa S, Shimizu M, Otani N, Ishimatsu S. Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020 10; 38(10):2243.e1-2243.e3. PMID: 32473756.
      Citations: 4     Fields:    Translation:Humans
    Hifumi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (179)
    Explore
    _
    Co-Authors (27)
    Explore
    _
    Similar People (60)
    Explore
    _